Rachel H Tan1,2, Jillian J Kril3, Ciara McGinley3, Mohammad Hassani1, Masami Masuda-Suzukake4, Masato Hasegawa4, Remika Mito3, Matthew C Kiernan5, Glenda M Halliday1,2. 1. Neuroscience Research Australia, Sydney, Australia. 2. School of Medical Sciences, University of New South Wales, Sydney, Australia. 3. Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, Australia. 4. Department of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan. 5. Brain and Mind Center, Sydney Medical School, The University of Sydney, Sydney, Australia.
Abstract
OBJECTIVE: Despite evidence suggesting that the cerebellum may be targeted in amyotrophic lateral sclerosis (ALS), particularly in cases with repeat expansions in the ATXN2 and C9ORF72 genes, the integrity of cerebellar neurons has yet to be examined. The present study undertakes a histopathological analysis to assess the impact of these repeat expansions on cerebellar neurons and determine whether similar cerebellar pathology occurs in sporadic disease. METHODS: Purkinje and granule cells were quantified in the vermis and lateral cerebellar hemispheres of ALS cases with repeat expansions in the ATXN2 and C9ORF72 genes, sporadic disease, and sporadic progressive muscular atrophy with only lower motor neuron degeneration. RESULTS: ALS cases with intermediate repeat expansions in the ATXN2 gene demonstrate a significant loss in Purkinje cells in the cerebellar vermis only. Despite ALS cases with expansions in the C9ORF72 gene having the highest burden of inclusion pathology, no neuronal loss was observed in this group. Neuronal numbers were also unchanged in sporadic ALS and sporadic PMA cases. INTERPRETATION: The present study has established a selective loss of Purkinje cells in the cerebellar vermis of ALS cases with intermediate repeat expansions in the ATXN2 gene, suggesting a divergent pathogenic mechanism independent of upper and lower motor neuron degeneration in ALS. We discuss these findings in the context of large repeat expansions in ATXN2 and spinocerebellar ataxia type 2, providing evidence that intermediate repeats in ATXN2 cause significant, albeit less substantial, spinocerebellar damage compared with longer repeats in ATXN2.
OBJECTIVE: Despite evidence suggesting that the cerebellum may be targeted in amyotrophic lateral sclerosis (ALS), particularly in cases with repeat expansions in the ATXN2 and C9ORF72 genes, the integrity of cerebellar neurons has yet to be examined. The present study undertakes a histopathological analysis to assess the impact of these repeat expansions on cerebellar neurons and determine whether similar cerebellar pathology occurs in sporadic disease. METHODS: Purkinje and granule cells were quantified in the vermis and lateral cerebellar hemispheres of ALS cases with repeat expansions in the ATXN2 and C9ORF72 genes, sporadic disease, and sporadic progressive muscular atrophy with only lower motor neuron degeneration. RESULTS:ALS cases with intermediate repeat expansions in the ATXN2 gene demonstrate a significant loss in Purkinje cells in the cerebellar vermis only. Despite ALS cases with expansions in the C9ORF72 gene having the highest burden of inclusion pathology, no neuronal loss was observed in this group. Neuronal numbers were also unchanged in sporadic ALS and sporadic PMA cases. INTERPRETATION: The present study has established a selective loss of Purkinje cells in the cerebellar vermis of ALS cases with intermediate repeat expansions in the ATXN2 gene, suggesting a divergent pathogenic mechanism independent of upper and lower motor neuron degeneration in ALS. We discuss these findings in the context of large repeat expansions in ATXN2 and spinocerebellar ataxia type 2, providing evidence that intermediate repeats in ATXN2 cause significant, albeit less substantial, spinocerebellar damage compared with longer repeats in ATXN2.
Authors: Mark T W Ebbert; Christian A Ross; Luc J Pregent; Rebecca J Lank; Cheng Zhang; Rebecca B Katzman; Karen Jansen-West; Yuping Song; Edroaldo Lummertz da Rocha; Carla Palmucci; Pamela Desaro; Amelia E Robertson; Ana M Caputo; Dennis W Dickson; Kevin B Boylan; Rosa Rademakers; Tamas Ordog; Hu Li; Veronique V Belzil Journal: Acta Neuropathol Date: 2017-08-14 Impact factor: 17.088
Authors: Mariely DeJesus-Hernandez; NiCole A Finch; Xue Wang; Tania F Gendron; Kevin F Bieniek; Michael G Heckman; Aliaksei Vasilevich; Melissa E Murray; Linda Rousseau; Rachael Weesner; Anthony Lucido; Meeia Parsons; Jeannie Chew; Keith A Josephs; Joseph E Parisi; David S Knopman; Ronald C Petersen; Bradley F Boeve; Neill R Graff-Radford; Jan de Boer; Yan W Asmann; Leonard Petrucelli; Kevin B Boylan; Dennis W Dickson; Marka van Blitterswijk; Rosa Rademakers Journal: Acta Neuropathol Date: 2017-05-15 Impact factor: 17.088
Authors: Peter Bede; Rangariroyashe H Chipika; Foteini Christidi; Jennifer C Hengeveld; Efstratios Karavasilis; Georgios D Argyropoulos; Jasmin Lope; Stacey Li Hi Shing; Georgios Velonakis; Léonie Dupuis; Mark A Doherty; Alice Vajda; Russell L McLaughlin; Orla Hardiman Journal: J Neurol Neurosurg Psychiatry Date: 2021-06-24 Impact factor: 10.154